📖
Time Course and Comparative Risk of Hypophosphatemia After Ferric Carboxymaltose versus Ferric Derisomaltose: A Systematic Review, Meta-analysis, and Clinical Cost Considerations.
Dangre V, Rafiuddin M, Sriram K, Aslam Siddiqui I, Fahim H, Sakthivel Murugan S, Copeta F, Ul Ain Fatima N, Eze B, Pokhrel S

Time Course and Comparative Risk of Hypophosphatemia After Ferric Carboxymaltose versus Ferric Derisomaltose: A Systematic Review, Meta-analysis, and Clinical Cost Considerations.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Hosp Pharm.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Time Course and Comparative Risk of Hypophosphatemia After Ferric Carboxymaltose versus Ferric Derisomaltose: A Systematic Review, Meta-analysis, and Clinical Cost Considerations.
Author / Organization Dangre V, Rafiuddin M, Sriram K, Aslam Siddiqui I, Fahim H, Sakthivel Murugan S, Copeta F, Ul Ain Fatima N, Eze B, Pokhrel S
Subject & Discipline Hosp Pharm
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-118820
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »